Market Overview:
The global fetal calf serum market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for fetal calf serum in research and development applications, and commercial production of biologics and pharmaceuticals. North America is expected to dominate the global fetal calf serum market, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa.
Product Definition:
Fetal calf serum is a nutrient-rich solution that is extracted from the blood of a fetus calf. It is used as a growth medium for cells in laboratory settings, and it also contains important proteins and antibodies that can promote cell growth.
North America-sourced:
North America-sourced fetal calf serum (FCS) is a product that has been obtained from the cord blood of the fetus, which is extracted from pregnant cows. It contains high amount of protein and various other ingredients such as vitamins, hormones, growth factors etc. The main function of this product is to help in healing wounds & damaged tissues and helps in stimulating new cells for wound healing process.
South America-sourced:
South America-sourced fetal calf serum (FCS) is a product that has been obtained from the blood of pregnant cows and processed to produce a sterile solution. It is used as an alternative to human fetal calf serum in the treatment of various diseases such as rheumatoid arthritis, osteoarthritis, and allergies in children.
Application Insights:
The research and development segment dominated the global market in 2017. The increasing R&D activities by various companies to develop new products based on application areas such as diagnostics, therapeutics and vaccines are expected to drive the demand for fetal calf serum over the forecast period.
Commercial production is estimated to be fastest growing segment owing to factors such as increasing number of biopharmaceutical companies that are producing proteins using bovine source materials due to high protein content, low cost and availability of a large number of animals per year. Moreover, several governments have passed laws legalizing animal-based sources for drug production which has further propelled growth in this segment. For instance, Brazil legalized commercialization of drugs produced from bovine sources in 1997 while Japan passed a law permitting human consumption of milk & milk products derived from cows reared under domestic conditions in 1981 (legalized since 1984). These favorable government policies coupled with rising awareness regarding bio-production is anticipated fuel product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The U.S., being a developed nation, has been at the forefront of technological advancements and fetal calf serum production methods. Moreover, high R&D investments by leading pharmaceutical companies in this region have fueled market growth over the past few years.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to increasing demand for medicines from countries such as China and India coupled with rising healthcare expenditure by regional governments and private players for developing healthcare infrastructure within their nations. Furthermore, Japan’s Ministry of Health, Labor & Welfare (MHLW) announced that it will lift its ban on imports from Denmark effective April 2018 which is anticipated to boost product demand in Asia Pacific Fetal Calf Serum Market over the forecast period (2018 - 2030).
Growth Factors:
- Increasing demand for fetal calf serum in the biotechnology and pharmaceutical industries for research and development purposes.
- Rising prevalence of chronic diseases such as cancer, diabetes, and heart diseases that require extensive research for their diagnosis and treatment. This is expected to drive the demand for fetal calf serum products over the forecast period.
- Growing investments by private players in life sciences sector to develop novel therapies using fetal calf serum products is another key factor driving market growth.
- Technological advancements in cell culture techniques that have led to increased use of Fetal Calf Serum (FCS) products across various applications are also propelling market growth .
Scope Of The Report
Report Attributes
Report Details
Report Title
Fetal Calf Serum Market Research Report
By Type
North America-sourced, South America-sourced, Australia-sourced, Others
By Application
Research & Development, Commercial Production
By Companies
Thermo Fisher, GE Healthcare, Sigma-Aldrich, Merck, Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen, Biowest, Internegocios, RMBIO, Biological Industries, PAN-Biotech, VWR, Corning
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Fetal Calf Serum Market Report Segments:
The global Fetal Calf Serum market is segmented on the basis of:
Types
North America-sourced, South America-sourced, Australia-sourced, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research & Development, Commercial Production
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- GE Healthcare
- Sigma-Aldrich
- Merck
- Moregate BioTech
- Gemini
- Atlanta Biologicals
- Tissue Culture Biologicals
- Bovogen
- Biowest
- Internegocios
- RMBIO
- Biological Industries
- PAN-Biotech
- VWR
- Corning
Highlights of The Fetal Calf Serum Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- North America-sourced
- South America-sourced
- Australia-sourced
- Others
- By Application:
- Research & Development
- Commercial Production
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fetal Calf Serum Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fetal calf serum (FCS) is a serum made from the blood of a calf that has been aborted. It is used to help treat certain medical conditions in newborn calves.
Some of the major companies in the fetal calf serum market are Thermo Fisher, GE Healthcare, Sigma-Aldrich, Merck, Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen, Biowest, Internegocios, RMBIO, Biological Industries, PAN-Biotech, VWR, Corning.
The fetal calf serum market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fetal Calf Serum Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fetal Calf Serum Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fetal Calf Serum Market - Supply Chain
4.5. Global Fetal Calf Serum Market Forecast
4.5.1. Fetal Calf Serum Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fetal Calf Serum Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fetal Calf Serum Market Absolute $ Opportunity
5. Global Fetal Calf Serum Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fetal Calf Serum Market Size and Volume Forecast by Type
5.3.1. North America-sourced
5.3.2. South America-sourced
5.3.3. Australia-sourced
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fetal Calf Serum Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fetal Calf Serum Market Size and Volume Forecast by Application
6.3.1. Research & Development
6.3.2. Commercial Production
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fetal Calf Serum Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fetal Calf Serum Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fetal Calf Serum Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fetal Calf Serum Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fetal Calf Serum Demand Share Forecast, 2019-2026
9. North America Fetal Calf Serum Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fetal Calf Serum Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fetal Calf Serum Market Size and Volume Forecast by Application
9.4.1. Research & Development
9.4.2. Commercial Production
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fetal Calf Serum Market Size and Volume Forecast by Type
9.7.1. North America-sourced
9.7.2. South America-sourced
9.7.3. Australia-sourced
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fetal Calf Serum Demand Share Forecast, 2019-2026
10. Latin America Fetal Calf Serum Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fetal Calf Serum Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fetal Calf Serum Market Size and Volume Forecast by Application
10.4.1. Research & Development
10.4.2. Commercial Production
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fetal Calf Serum Market Size and Volume Forecast by Type
10.7.1. North America-sourced
10.7.2. South America-sourced
10.7.3. Australia-sourced
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fetal Calf Serum Demand Share Forecast, 2019-2026
11. Europe Fetal Calf Serum Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fetal Calf Serum Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fetal Calf Serum Market Size and Volume Forecast by Application
11.4.1. Research & Development
11.4.2. Commercial Production
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fetal Calf Serum Market Size and Volume Forecast by Type
11.7.1. North America-sourced
11.7.2. South America-sourced
11.7.3. Australia-sourced
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projecions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fetal Calf Serum Demand Share, 2019-2026
12. Asia Pacific Fetal Calf Serum Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fetal Calf Serum Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fetal Calf Serum Market Size and Volume Forecast by Application
12.4.1. Research & Development
12.4.2. Commercial Production
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fetal Calf Serum Market Size and Volume Forecast by Type
12.7.1. North America-sourced
12.7.2. South America-sourced
12.7.3. Australia-sourced
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fetal Calf Serum Demand Share, 2019-2026
13. Middle East & Africa Fetal Calf Serum Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fetal Calf Serum Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fetal Calf Serum Market Size and Volume Forecast by Application
13.4.1. Research & Development
13.4.2. Commercial Production
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fetal Calf Serum Market Size and Volume Forecast by Type
13.7.1. North America-sourced
13.7.2. South America-sourced
13.7.3. Australia-sourced
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fetal Calf Serum Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fetal Calf Serum Market: Market Share Analysis
14.2. Fetal Calf Serum Distributors and Customers
14.3. Fetal Calf Serum Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GE Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sigma-Aldrich
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Moregate BioTech
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Gemini
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Atlanta Biologicals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Tissue Culture Biologicals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bovogen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Biowest
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Internegocios
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. RMBIO
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Biological Industries
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. PAN-Biotech
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. VWR
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Corning
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
